Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity / Member's (Deficit)

v3.20.2
Condensed Consolidated Statements of Shareholders' Equity / Member's (Deficit) - USD ($)
$ in Thousands
Total
Common Shares
Additional  Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2019   0          
Beginning balance at Mar. 31, 2019 $ (390,258) $ 0 $ (184,546) $ (176,002) $ (29,710)    
Increase (Decrease) in Partners' Capital [Roll Forward]              
Foreign currency translation, net of tax 4,528       4,528    
Reclassification of related party payable upon reorganization 600,622   600,622        
Issuance of common stock in connection with initial public offering, net of underwriters' discounts and commissions and issuance costs (in shares)   38,873,000          
Issuance of common stock in connection with initial public offering, net of underwriters' discounts and commissions and issuance costs 585,297 $ 39 585,258        
Effect of reorganization (in shares)   241,547,000          
Effect of reorganization 278,248 $ 242 271,383   6,623    
Contribution for taxes associated with reorganization 265,000   265,000        
Restricted stock units vested (in shares)   89,000          
Share-based compensation 9,479   9,479        
Equity repurchases (145)   (145)        
Net income (loss) (466,489)     (466,489)      
Ending balance (in shares) at Sep. 30, 2019   280,509,000          
Ending balance at Sep. 30, 2019 886,282 $ 281 1,547,051 (642,491) (18,559)    
Beginning balance (in shares) at Jun. 30, 2019   0          
Beginning balance at Jun. 30, 2019 (437,629) $ 0 (184,599) (225,157) (27,873)    
Increase (Decrease) in Partners' Capital [Roll Forward]              
Foreign currency translation, net of tax 2,691       2,691    
Reclassification of related party payable upon reorganization 600,622   600,622        
Effect of reorganization (in shares)   241,547,000          
Effect of reorganization 278,248 $ 242 271,383   6,623    
Contribution for taxes associated with reorganization 265,000   265,000        
Restricted stock units vested (in shares)   89,000          
Issuance of common stock related to employee stock purchase plan (in shares)   38,873,000          
Issuance of common stock related to employee stock purchase plan 585,297 $ 39 585,258        
Share-based compensation 9,479            
Equity repurchases (92)   (92)        
Net income (loss) (417,334)     (417,334)      
Ending balance (in shares) at Sep. 30, 2019   280,509,000          
Ending balance at Sep. 30, 2019 886,282 $ 281 1,547,051 (642,491) (18,559)    
Increase (Decrease) in Partners' Capital [Roll Forward]              
Cumulative effects adjustment for ASU 2016-02 adoption $ 961,497 $ 281 1,573,347 (594,026) (18,105) $ 306 $ 306
Beginning balance (in shares) at Mar. 31, 2020 280,853,040 280,853,000          
Beginning balance at Mar. 31, 2020 $ 961,497 $ 281 1,573,347 (594,026) (18,105) 306 306
Increase (Decrease) in Partners' Capital [Roll Forward]              
Foreign currency translation, net of tax (5,134)       (5,134)    
Restricted stock units vested (in shares)   806,000          
Restricted stock awards forfeited (in shares)   (96,000)          
Issuance of common stock related to employee stock purchase plan (in shares)   159,000          
Issuance of common stock related to employee stock purchase plan $ 3,592   3,592        
Exercise of stock options (in shares) 302,000 302,000          
Exercise of stock options $ 4,829   4,829        
Share-based compensation 27,503   27,503        
Equity repurchases (25)   (25)        
Cumulative effects adjustment for ASU 2016-02 adoption 1,022,912 $ 281 1,573,347 (594,026) (18,105) $ 306 $ 306
Net income (loss) $ 30,344     30,344      
Ending balance (in shares) at Sep. 30, 2020 282,023,558 282,024,000          
Ending balance at Sep. 30, 2020 $ 1,022,912 $ 281 1,609,246 (563,376) (23,239)    
Increase (Decrease) in Partners' Capital [Roll Forward]              
Cumulative effects adjustment for ASU 2016-02 adoption 988,577 $ 281 1,589,598 (580,855) (20,447)    
Beginning balance (in shares) at Jun. 30, 2020   281,056,000          
Beginning balance at Jun. 30, 2020 988,577 $ 281 1,589,598 (580,855) (20,447)    
Increase (Decrease) in Partners' Capital [Roll Forward]              
Foreign currency translation, net of tax (2,792)       (2,792)    
Restricted stock units vested (in shares)   674,000          
Restricted stock awards forfeited (in shares)   (8,000)          
Exercise of stock options (in shares)   302,000          
Exercise of stock options 4,829   4,829        
Share-based compensation 14,831   14,831        
Equity repurchases (12)   (12)        
Cumulative effects adjustment for ASU 2016-02 adoption 1,022,912 $ 281 1,609,246 (563,376) (23,239)    
Net income (loss) $ 17,479     17,479      
Ending balance (in shares) at Sep. 30, 2020 282,023,558 282,024,000          
Ending balance at Sep. 30, 2020 $ 1,022,912 $ 281 1,609,246 (563,376) (23,239)    
Increase (Decrease) in Partners' Capital [Roll Forward]              
Cumulative effects adjustment for ASU 2016-02 adoption $ 1,022,912 $ 281 $ 1,609,246 $ (563,376) $ (23,239)